日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epidemiology of Firework-Related Eye Injuries From 2002 to 2021

2002年至2021年烟花相关眼损伤的流行病学研究

Jaber, Jay; Pluenneke, Molly; Huang, Austin; Zhao, Madison; Lee, Andrew G

Early amiodarone or lidocaine administration during in-hospital cardiac arrest caused by shockable rhythms

院内发生可电击心律引起的心脏骤停时,早期应用胺碘酮或利多卡因

Paganoni, Rafael C; Pluenneke, Jack C; Mohamed, Adham M; Hayes, Charles H 3rd; Freiberger-O'Keefe, Carole E; Chan, Paul S

IT TAKES TWO TO TANGO: potential novel therapies for autosomal dominant optic atrophy

合作需要双方:常染色体显性遗传性视神经萎缩的潜在新疗法

Sampige, Ritu; Seaborn, Lyra E A; Pluenneke, Molly; Jyothi, Annika; Saland, Sophie; Chinedu-Obi, Chisom M; Keehn, Caroline; Lee, Andrew G

Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial

随机对照试验比较固定剂量卡培他滨与标准剂量卡培他滨治疗转移性乳腺癌的疗效:X-7/7试验

Khan, Qamar J; Bohnenkamp, Colleen; Monson, Taylor E; Phadnis, Milind A; Clark, Lauren; Smith, Holly E; Raja, Vinay; Elia, Manana; O'Dea, Anne; Fesen, Mark R; Crane, Gregory J; Nye, Lauren E; Baranda, Joaquina C; Pluenneke, Robert E; Hoffmann, Marc; Al-Rajabi, Raed Moh'd Taiseer; Kasi, Anup; McKittrick, Richard J; Mitchell, Laura; LaFaver, Stephanie; Sharma, Priyanka

Quantifying Critical Care Pharmacist Interventions in COVID-19

量化重症监护药师在新冠肺炎疫情中的干预措施

Pluenneke, Jack C; Semler, Matthew W; Casey, Jonathan D; Qian, Edward T; Rice, Todd W; Stollings, Joanna L

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

雌激素/孕激素受体低表达与阴性状态对HER2阴性乳腺癌临床病理特征和生存结局的影响

Yoder, Rachel; Kimler, Bruce F; Staley, Joshua M; Schwensen, Kelsey; Wang, Yen Y; Finke, Karissa; O'Dea, Anne; Nye, Lauren; Elia, Manana; Crane, Gregory; McKittrick, Richard; Pluenneke, Robert; Madhusudhana, Sheshadri; Beck, Larry; Shrestha, Anuj; Corum, Larry; Marsico, Mark; Stecklein, Shane R; Godwin, Andrew K; Khan, Qamar J; Sharma, Priyanka

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)

随机 II 期试验比较 I-III 期三阴性乳腺癌患者接受不含蒽环类药物和含蒽环类药物的新辅助卡铂化疗方案(NeoSTOP)

Sharma, Priyanka; Kimler, Bruce F; O'Dea, Anne; Nye, Lauren; Wang, Yen Y; Yoder, Rachel; Staley, Joshua M; Prochaska, Lindsey; Wagner, Jamie; Amin, Amanda L; Larson, Kelsey; Balanoff, Christa; Elia, Manana; Crane, Gregory; Madhusudhana, Sheshadri; Hoffmann, Marc; Sheehan, Maureen; Rodriguez, Roberto; Finke, Karissa; Shah, Rajvi; Satelli, Deepti; Shrestha, Anuj; Beck, Larry; McKittrick, Richard; Pluenneke, Robert; Raja, Vinay; Beeki, Venkatadri; Corum, Larry; Heldstab, Jaimie; LaFaver, Stephanie; Prager, Micki; Phadnis, Milind; Mudaranthakam, Dinesh Pal; Jensen, Roy A; Godwin, Andrew K; Salgado, Roberto; Mehta, Kathan; Khan, Qamar